Red cell autoimmunization and alloimmunization in myelodysplastic syndromes: prevalence, characteristic and significance.
作者信息
Chhetri Rakchha, Wee Li Yan A, Sinha Romi, Kutyna Monika M, Pham Anh, Stathopoulos Helen, Nath Lakshmi, Nath Shriram V, Wickham Nicholas, Hughes Tim, Singhal Deepak, Roxby David J, Hiwase Devendra K
机构信息
Haematology Department, Royal Adelaide Hospital, Central Adelaide Local Health Network.
Precision Medicine, South Australian Health and Medical Research Institute.
出版信息
Haematologica. 2019 Oct;104(10):e451-e454. doi: 10.3324/haematol.2018.215087. Epub 2019 Feb 28.
Abstract
摘要
相似文献
1
Red cell autoimmunization and alloimmunization in myelodysplastic syndromes: prevalence, characteristic and significance.
Haematologica. 2019 Oct;104(10):e451-e454. doi: 10.3324/haematol.2018.215087. Epub 2019 Feb 28.
2
Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database.
Br J Haematol. 2018 Jun;181(5):672-681. doi: 10.1111/bjh.15182. Epub 2018 Apr 19.
3
Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome.
Haematologica. 2017 Dec;102(12):2021-2029. doi: 10.3324/haematol.2017.175752. Epub 2017 Oct 5.
4
[Immunohematologic study in 112 patients with myelodysplastic syndromes: 10-year analysis].
Sangre (Barc). 1995 Jun;40(3):177-80.
5
Red blood cell alloimmunization: lessons from sickle cell disease.
Transfusion. 2013 Apr;53(4):692-5. doi: 10.1111/trf.12146.
6
Clinical Utility of Flow Cytometry for Detection of Anti-Jk IgM in Acute Haemolytic Transfusion Reaction.
Intern Med. 2024 May 1;63(9):1273-1275. doi: 10.2169/internalmedicine.2639-23. Epub 2023 Sep 29.
7
Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes.
Vox Sang. 2017 Jan;112(1):79-86. doi: 10.1111/vox.12455. Epub 2016 Oct 19.
8
Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
Transfusion. 2013 Apr;53(4):710-5. doi: 10.1111/j.1537-2995.2012.03819.x. Epub 2012 Jul 31.
9
Red Blood Cell Alloimmunization in Multitransfused Pediatric Population in a Tertiary Care Hospital.
Indian J Pediatr. 2019 Mar;86(3):245-249. doi: 10.1007/s12098-018-2815-9. Epub 2018 Dec 4.
10
Impact of azacitidine on red blood cell alloimmunisation in myelodysplastic syndrome.
Blood Transfus. 2017 Sep;15(5):472-477. doi: 10.2450/2016.0012-16. Epub 2016 Jun 24.
引用本文的文献
1
How I treat anemia with red blood cell transfusion and iron.
Blood. 2023 Aug 31;142(9):777-785. doi: 10.1182/blood.2022018521.
2
Somatic mutations show no clear association with red blood cell or human leukocyte antigen alloimmunization in de novo or therapy-related myelodysplastic syndrome.
Transfusion. 2022 Dec;62(12):2470-2479. doi: 10.1111/trf.17155. Epub 2022 Oct 24.
3
A clinical effect of disease-modifying treatment on alloimmunisation in transfused patients with myelodysplastic syndromes: data from a population-based study.
Blood Transfus. 2022 Jan;20(1):18-26. doi: 10.2450/2020.0168-20. Epub 2020 Dec 16.
4
Outpatient transfusions for myelodysplastic syndromes.
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):167-174. doi: 10.1182/hematology.2020000103.
本文引用的文献
1
Clinical and epidemiological profile of alloimmunized and autoimmunized multi-transfused patients against red blood cell antigens in a blood center of Minas Gerais.
Hematol Transfus Cell Ther. 2018 Apr-Jun;40(2):107-111. doi: 10.1016/j.htct.2017.08.001. Epub 2018 Feb 17.
2
Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome.
Haematologica. 2017 Dec;102(12):2021-2029. doi: 10.3324/haematol.2017.175752. Epub 2017 Oct 5.
3
Molecular matching for Rh and K reduces red blood cell alloimmunisation in patients with myelodysplastic syndrome.
Blood Transfus. 2015 Jan;13(1):53-8. doi: 10.2450/2014.0332-13. Epub 2014 Jun 12.
4
Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
Transfusion. 2013 Apr;53(4):710-5. doi: 10.1111/j.1537-2995.2012.03819.x. Epub 2012 Jul 31.
5
Regulatory T-cell status in red cell alloimmunized responder and nonresponder mice.
Blood. 2009 May 28;113(22):5624-7. doi: 10.1182/blood-2008-12-193748. Epub 2009 Mar 31.
6
Coexistence of autoantibodies and alloantibodies to red blood cells due to blood transfusion.
Transfusion. 2007 May;47(5):813-6. doi: 10.1111/j.1537-2995.2007.01194.x.
7
Warm reactive autoantibodies: clinical and serologic correlations.
Am J Clin Pathol. 2004 Nov;122(5):680-5. doi: 10.1309/CJAW-6N8J-6H0H-R2WM.
8
Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolytic anemia?
Transfusion. 2004 Jan;44(1):67-72. doi: 10.1046/j.0041-1132.2003.00589.x.
9
Interleukin-10-mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen.
Blood. 2002 Dec 15;100(13):4529-36. doi: 10.1182/blood-2002-05-1383. Epub 2002 Aug 1.
10
Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
Transfusion. 2002 Jan;42(1):37-43. doi: 10.1046/j.1537-2995.2002.00007.x.
Zotero 插件